heart data Articles
-
Vectorious reports positive results from VECTOR-HF I study of V-LAP system
The first clinical data of an implantable heart sensor with remote measurement capacity was presented at the prestigious ESC Heart Failure 2022 Late-Breaking Science event Israel-based Vectorious Medical Technologies announced the positive results from the VECTOR-HF I study of its V-LAP novel wireless system. The first-in-man clinical study was intended to check the safety, ease of use, and ...
By Vectorious
-
Ancora Heart Announces Positive Safety and Efficacy Data from Study of First-of-Its-Kind Investigational Heart Failure Therapy
Interim study results from systolic heart failure patients treated with percutaneous therapy designed to improve left ventricular function presented at TCT 2019 Santa Clara, Calif.–September 25, 2019–Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced results from an interim analysis of heart failure patients treated in the CorCinch FMR ...
-
A Moment Matching Approach for Generating Synthetic Data
ABSTRACT Synthetic data are becoming increasingly important mechanisms for sharing data among collaborators and with the public. Multiple methods for the generation of synthetic data have been proposed, but many have short comings with respect to maintaining the statistical properties of the original data. We propose a new method for fully synthetic data generation that leverages linear ...
-
A single contact lens could give your entire life a head-up display
Mojo Vision's smart contacts put text in my eye and let me see in the dark. The company is aiming for even more than that. There aren't many meetings in Las Vegas during CES that still make my jaw drop. The few I can think of mostly involved Oculus. I had no idea what a company I've never met with before, called Mojo Vision, was going to show me. I knew they made very, very small displays. I ...
-
Vectorious Begins the VECTOR-HF II Study of its Implantable In-Heart Sensor for Left Atrial Pressure-Guided Patient Self-Management of Heart Failure
For the first time, heart failure patients can have full visibility of their hearts’ LA pressure and self-adjust their medication to stop further deterioration and avoid hospitalizations April 26, 2022 08:30 AM Eastern Daylight Time TEL AVIV, Israel–(BUSINESS WIRE)–Vectorious Medical Technologies Ltd., today announced that it has enrolled the first six patients in the ...
By Vectorious
-
Vectorious’ in-heart microcomputer wins FDA breakthrough nod
Vectorious Medical Technologies today announced that the FDA has granted breakthrough device designation for the company’s left atrial pressure (LAP) monitoring device. The V-LAP system is the first digital, wireless, battery-free device that can communicate from deep within the body using high-resolution waveform morphology, according to the Tel Aviv-based startup. Because the pressure of ...
By Vectorious
-
Pulse Oximetry with Clinical Assessment to Screen for Congenital Heart Disease in Neonates in China: A Prospective Study - Case study
Background Several pioneering studies have provided evidence for the introduction of universal pulse oximetry screening for critical congenital heart disease. I lowever, whether the benefits of screening reported in studies from high-income countries would translate with similar success to low-income countries is unknown. We assessed the feasibility and reliability of pulse oximetry plus clinical ...
By Masimo Corp
-
AI’s Evolving Role in Monitoring and Treating Sleep Disorders
Obstructive sleep apnea (OSA) is a serious and life-threatening condition. Approximately 5.9 million adults are diagnosed with OSA, but as many as 23 million people are estimated to be dealing with OSA yet go undiagnosed. The impact on health can be significant, ranging from inconveniences to life-threatening illnesses. Obstructive sleep apnea can cause disrupted sleep for both OSA sufferers and ...
-
VIC Portfolio Companies and Pipeline Technologies with Pandemic Impact
Our current daily activities bear little resemblance to the routines as of as recently as a month ago. COVID-19 has had an obvious and significant impact on the American people. For those suffering from chronic conditions such as dementia, diabetes, heart and respiratory disease, the health impact during traumatic periods such as this is magnified. The COVID-19 pandemic has disrupted our ...
-
What causes heart failure with preserved ejection fraction (HFpEF)?
Heart failure with preserved ejection fraction (HFpEF) is a multifactorial and multisystemic disorder that represents more than 50% of all heart failure cases.[1] Epidemiologic data from the Framingham Study, an international cohort study, shows a rapid increase in the prevalence of HFpEF over the past three decades, from 41% to 56% and, conversely, a decrease in the prevalence of HFrEF from 44% ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you